Senior insider sale
IMMUNOVANT, INC. — senior position signals high conviction
$537.3K
22.25K shares
What this filing means
FROMKIN ANDREW J. plans to sell 22.25K shares of IMMUNOVANT, INC. valued at approximately $537.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001950047-25-009565
22.25K
Shares to sell
$537.3K
Approx. market value
22.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/10/2022
22.25KTotal acquired22.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/10/2022 | Restricted Stock Units N/A | 22.25K | — |
| Total | 22.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.25K
Market value
$537.3K
12/1/2025
Total
Units
22.25K
Value
$537.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/1/2025 | 22.25K | $537.3K | NASDAQ | Planned |
| Total | 22.25K | $537.3K | ||